Caplacizumab

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 377 publications

Microfluidic Shear-Based Assay for Assessing ADAMTS13 Activity Under Flow.

Microfluidic Shear-Based Assay for Assessing ADAMTS13 Activity Under Flow.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 31, 2026

Treating Immune-Mediated Thrombotic Thrombocytopenic Purpura with Caplacizumab.

Treating Immune-Mediated Thrombotic Thrombocytopenic Purpura with Caplacizumab.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 31, 2026

Thrombotic thrombocytopenic purpura in pregnancy: Lessons from a case series of three patients.

Thrombotic thrombocytopenic purpura in pregnancy: Lessons from a case series of three patients.

Journal: The Journal of international medical research

Published: March 19, 2026

Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipients.

Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipients.

Journal: The Journal of clinical investigation

Published: March 10, 2026

The interface of hemostasis and inflammation: endothelial-platelet dynamics in thrombosis.

The interface of hemostasis and inflammation: endothelial-platelet dynamics in thrombosis.

Journal: Current opinion in hematology

Published: March 10, 2026

Case Series and Literature Narrative Review of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Children.

Case Series and Literature Narrative Review of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Children.

Journal: Children (Basel, Switzerland)

Published: February 06, 2026

Immune-mediated thrombotic thrombocytopenic purpura successfully diagnosed and treated through repeated ADAMTS13 inhibitor testing

Immune-mediated thrombotic thrombocytopenic purpura successfully diagnosed and treated through repeated ADAMTS13 inhibitor testing

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 01, 2026

Thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus after anifrolumab: a possible association.

Thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus after anifrolumab: a possible association.

Journal: Archive of clinical cases

Published: January 21, 2026

Pregnancy-Associated Thrombotic Thrombocytopenic Purpura: Diagnostic Pitfalls, Therapeutic Strategies, and Emerging Paradigms.

Pregnancy-Associated Thrombotic Thrombocytopenic Purpura: Diagnostic Pitfalls, Therapeutic Strategies, and Emerging Paradigms.

Journal: Biomedicines

Published: January 21, 2026

Epidemiology, therapy, and outcome of immune-mediated thrombotic thrombocytopenic purpura at population level in Germany.

Epidemiology, therapy, and outcome of immune-mediated thrombotic thrombocytopenic purpura at population level in Germany.

Journal: Research and practice in thrombosis and haemostasis

Published: December 23, 2025

Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS database.

Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS database.

Journal: Thrombosis journal

Published: December 16, 2025

Tailored treatment of acute immune-mediated thrombotic thrombocytopenic purpura.

Tailored treatment of acute immune-mediated thrombotic thrombocytopenic purpura.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Showing 1-12 of 377

Last Updated: 04/28/2026